ArticleScientific reports2025
Machine learning assisted adjustment boosts efficiency of exact inference in randomized controlled trials.
Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Article
- Strategies to boost statistical efficiency in randomized oncology trials with primary time-to-event endpoints.Statistical methods in medical research · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
Abstract
In this work, we proposed a novel inferential procedure assisted by machine learning based adjustment for randomized control trials. The method was developed under the Rosenbaum's framework of exact tests in randomized experiments with covariate adjustments, replacing the traditional linear model with nonparametric models that capture the complex relationships between covariates and outcomes. Through extensive simulation experiments, we showed the proposed method can robustly control the type I error and can boost the statistical efficiency for a randomized controlled trial (RCT). This advantage was further demonstrated in a real-world example. The simplicity, flexibility, and robustness of the proposed method makes it a competitive candidate as a routine inference procedure for RCTs, especially when nonlinear association or interaction among covariates is expected. Its application may remarkably reduce the required sample size and cost of RCTs, such as phase III clinical trials.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.